ACTIVATE Trademark of Select Therapeutics, Inc. - Serial Number 76252088

Trademark Overview

On Friday, May 4, 2001, a trademark application was filed for ACTIVATE with the United States Patent and Trademark Office. The USPTO has given the ACTIVATE trademark a serial number of 76252088. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 6, 2002. This trademark is owned by Select Therapeutics, Inc.. The ACTIVATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

treatment of disease; providing products and research services and generation and manipulation services relating to the treatment of disease through antigen delivery

General Information

Serial Number	76252088
Word Mark	ACTIVATE
Filing Date	Friday, May 4, 2001
Status	602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status Date	Monday, May 6, 2002
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

Goods and Services

treatment of disease; providing products and research services and generation and manipulation services relating to the treatment of disease through antigen delivery

Classification Information

International Class	042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes	100, 101
Class Status Code	6 - Active
Class Status Date	Thursday, May 17, 2001
Primary Code	042
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	Select Therapeutics, Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Woburn, MA 01801

Trademark Events

Event Date	Event Description
Monday, May 6, 2002	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 13, 2001	NON-FINAL ACTION MAILED
Sunday, August 12, 2001	ASSIGNED TO EXAMINER

Related Keywords

activate treatment services disease through antigen delivery relating generation products research